Skip to main content
. 2015 Oct 2;169(4):2950–2962. doi: 10.1104/pp.15.01391

Table I. PBL13 phosphopeptides identified by LC-MS/MS analysis.

Recombinant His6-PBL13 and His6-PBL13K111A were subjected to in vitro kinase assays followed by trypsin digestion and TiO2 phosphopeptide enrichment before LC-MS/MS analyses. Phosphopeptide spectra were analyzed using the LuciPHOr algorithm for perform phosphosite localization. Reported phosphopeptides required a LuciPHOr global false localization rate score of less than 0.05 and were manually validated. No phosphorylated peptides were identified from His6-PBL13K111A samples; s, t, and y denote phosphorylated Ser, Thr, and Tyr, respectively, whereas m and e denote oxidized Met and dehydrated Glu, respectively.

Residue Peptide Sequence
S240 (K)DGPQGDDTHVsTR(V)
S321 (R)LEDQYsEtGAR(K)
T323 (R)LEDQYSEtGARK(A)
T383 and S384 or T443 and S444 (R)REVKEtsLQNFDKPR(R/N)
T383 or 428 or T443 (R)REVKEtSLQNFDK(P/T)
T383 or T443 (R)EVKEtSLQNFDKPR(R/N)
S384 or S429 or S444 (R)EVKETsLQNFDK(P/T)
S384 or S444 (R)eVKETsLQNFDKPR(R/N)
T395, T398 (R)REtKVtSLQNFDK(T)
T395 (R)REtKVTSLQNFDK(T)
T398 (R)RETKVtSLQNFDKTR(R)
T406 (K)VTSLQNFDKtRR(E)
T413 (R)EVKDtSLQNFDK(T)
T421 (R)EVKDTSLQNFDKtRR(E)
S455 AND T456 (R)NVstTDNHQKFR(S)
S455 (R)NVsTTDNHQK(F)
Y481 (R)NGyNSPmRNEAGGERY-